EX-10.36 12 d244198dex1036.htm TOLL MANUFACTURING AGREEMENT *** Text Omitted and Filed Separately Confidential Treatment Requested Under 17 C.F.R. §§ 200.80(b)(4) and 203.406 TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • May 5th, 2020
THIS TOLL MANUFACTURING AGREEMENT (the “Agreement”), signed on September 30th, 2010, is made and entered into by and among Agro Industrie Recherches et Développements, S.A., a French entity (“ARD”), Bioamber, S.A.S., a French entity (“Bioamber”) and DNP Green Technology, Inc., a Delaware corporation (“DNP Green”).
FIRST AMENDMENT TO THE TOLL MANUFACTURING AGREEMENT DATED SEPTEMBER 15, 2004 BETWEEN GENENTECH, INC. AND WYETHToll Manufacturing Agreement • February 17th, 2006 • Genentech Inc • Pharmaceutical preparations
This amendment (the “Amendment”), effective as of December 8, 2004, is made by and between Genentech, Inc., a Delaware corporation having a principal place of business at 1 DNA Way, South San Francisco, California 94080 (“Genentech”), and Wyeth, a Delaware corporation acting through its Wyeth Pharmaceuticals Division having its principal place of business at Five Giralda Farms, Madison, New Jersey 07940 (“Wyeth”). Wyeth and Genentech are referred to herein collectively as the “Parties.”
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • July 23rd, 2010 • China Kanghui Holdings
In the principle of equality, good faith and mutual benefit and upon consultation, Party A and Party B agree that Party B will manufacture for Party A dental implant parts and accessories surgical instruments for dental implant on the terms set forth below:
BY AND BETWEEN SOLUTIA INC. ANDToll Manufacturing Agreement • November 9th, 2005 • Solutia Inc • Chemicals & allied products • Illinois
RESTATED TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • February 15th, 2013 • BioAmber Inc. • Industrial organic chemicals
THIS RESTATED TOLL MANUFACTURING AGREEMENT (the “Agreement”), signed as of December 7, 2012 (the “Signature Date”), with an effective date as of December 1st, 2011 (the “Effective Date”), is made and entered into by and among Agro Industrie Recherches et Développements, S.A., a French entity (“ARD”), BioAmber S.A.S., a French entity (“BioAmber”) and BioAmber Inc., a Delaware corporation (“BioAmber US”).
Confidential treatment requested on certain portions of this agreement. An unredacted version of this agreement has been filed separately with the Securities and Exchange Commission. FOURTH AMENDMENT TO TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 1st, 2011 • Kinetic Concepts Inc • Miscellaneous furniture & fixtures
This Fourth Amendment (this “Amendment”) to the Toll Manufacturing Agreement, effective as of August 1, 2010 (the “Amendment Effective Date”), is made by and between KCI Manufacturing (“KCI”) and Avail Medical Products, Inc. (“Avail”). Avail and KCI are referred to herein as the “Parties.”
RECITALSToll Manufacturing Agreement • December 31st, 1997 • Cmi Corp • Construction machinery & equip • Oklahoma
TOLL MANUFACTURING AGREEMENT By and Between WYETH, Acting through its Wyeth Pharmaceuticals Division and GENENTECH, INC.Toll Manufacturing Agreement • November 4th, 2005 • Genentech Inc • Pharmaceutical preparations • Delaware
This TOLL MANUFACTURING AGREEMENT (the "Agreement") is made effective as of September 15, 2004 (the "Effective Date"), by and between Wyeth, a Delaware corporation acting through its Wyeth Pharmaceuticals Division having its principal place of business at Five Giralda Farms, Madison, New Jersey 07940 ("Wyeth"), and Genentech, Inc., a Delaware corporation, having its principal place of business at One DNA Way, South San Francisco, California 94080 ("Genentech"). Wyeth and Genentech may each be referred to herein individually as a "Party" and collectively as the "Parties."
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 5th, 2008 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
WHEREAS, SIEGFRIED wishes to purchase from ARENA bulk tablets/capsules and packaged tablets/capsules for commercial sale by SIEGFRIED or SIEGFRIED’s partners.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • September 7th, 2020
This Toll Manufacturing Agreement (this “Agreement”) is made as of the __________ (the “Effective Date”) by and between __________ ("Company), an individual located at __________, __________, __________ __________ and __________ ("Manufacturer"), an individual located at __________, __________, __________ __________.
RESTATED TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • April 1st, 2013 • BioAmber Inc. • Industrial organic chemicals
THIS RESTATED TOLL MANUFACTURING AGREEMENT (the “Agreement”), signed as of December 7, 2012 (the “Signature Date”), with an effective date as of December 1st, 2011 (the “Effective Date”), is made and entered into by and among Agro Industrie Recherches et Développements, S.A., a French entity (“ARD”), BioAmber S.A.S., a French entity (“BioAmber”) and BioAmber Inc., a Delaware corporation (“BioAmber US”).
EXHIBIT 10.12 AMENDMENT TO TOLL MANUFACTURING AGREEMENT AGREEMENT dated as of this day of December, 1994 between PUREPAC PHARMACEUTICAL CO., a Delaware Corporation, having its principal office at 200 Elmora Avenue, Elizabeth, NJ 07207 ("Purepac"), and...Toll Manufacturing Agreement • September 29th, 1995 • Purepac Inc/ • Pharmaceutical preparations
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • February 11th, 2005 • Amphastar Pharmaceuticals, Inc. • New Jersey
THIS AGREEMENT effective this 26 day of June, 2003 (hereinafter referred to as the "effective date") by and between Amphastar Pharmaceuticals, Inc., a corporation organized under the law of the State of California, having its principal office at 11570 Sixth St., Rancho Cucamonga, CA 91730 (hereinafter "AMPHASTAR"), and ORGANON USA INC., a corporation organized under that laws of New Jersey, having its principal office at 375 Mt. Pleasant Avenue, West Orange, New Jersey 07052 (hereinafter "ORGANON").
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • November 6th, 2020
☐ corporation ☐ limited liability company ☐ partnership ☐ limited partnership ☐ limited liability partnership located at ________________________________________ [Address] and
State of TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • November 10th, 2020
AMENDMENT NO. 2 TO THE TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 16th, 2010 • Arena Pharmaceuticals Inc • Pharmaceutical preparations
This Amendment No. 2 (the “Amendment”), effective September 17, 2009, is by and between Arena Pharmaceuticals GmbH (“Arena”) and Siegfried Ltd. (“Siegfried”), and modifies the Toll Manufacturing Agreement, dated January 7, 2008, as amended, by and between Arena and Siegfried (the “Agreement”). All capitalized terms used herein and not otherwise defined shall have the meanings set forth in the Agreement.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • June 28th, 2011 • Myriant Corp • Industrial organic chemicals • New York
Before the development start up phase is initiated, CUSTOMER will specify the type of Raw Materials are required for producing the Fermentation Product and the specification and quality required. Fermic will be responsible for maintaining such Raw Material specifications and quality.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • March 16th, 2006 • Alpharma Inc • Pharmaceutical preparations • New Jersey
THIS TOLL MANUFACTURING AGREEMENT (the "Agreement") is made on 19th of December, 2005 ("Effective Date") between ALPHARMA BRANDED PRODUCTS DIVISION INC., a Delaware corporation ("Alpharma"), and PUREPAC PHARMACEUTICAL CO., a Delaware corporation ("Purepac"). Alpharma and Purepac are each individually a "Party" and are collectively the "Parties".
AVAIL MEDICAL PRODUCTS, INC. & KCI MANUFACTURING TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • February 26th, 2008 • Kinetic Concepts Inc /Tx/ • Miscellaneous furniture & fixtures • Texas
This Toll Manufacturing Agreement (this "Agreement") is entered into as of December 14, 2007, by and between on the first part KCI Manufacturing, a company incorporated under the laws of Ireland, with an address of Athlone Business & Technology Park, Garrycastle, Athlone, Co. Westmeath, Ireland ("KCI Manufacturing") and on the second part Avail Medical Products, Inc., a Delaware corporation with principal offices at 1600 Wells Fargo Tower, 201 Main Street, Fort Worth, Texas 76102 (collectively "Avail"). This Agreement will be effective as of November 30, 2007 (the "Effective Date"). Either Avail or KCI Manufacturing may be referred to herein as a “Party” or collectively as the “Parties.”
AMENDMENT TO TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • November 5th, 2008 • Kinetic Concepts Inc /Tx/ • Miscellaneous furniture & fixtures
This Amendment (this “Amendment”) to the Toll Manufacturing Agreement, dated as of July 31, 2008 (“Amendment Effective Date”), is made by and between KCI Manufacturing (“KCI”) and Avail Medical Products, Inc.(“Avail”). Avail and KCI are referred to herein as the “Parties”.
TOLL MANUFACTURING AGREEMENTToll Manufacturing Agreement • July 1st, 2021 • California
This Toll Manufacturing Agreement (this “Agreement”) is made as of the 05 day of January, 2018 (the “Effective Date”) by and between Alex Pally ("Company), an individual located at 2901 Kerry Lane, San Francisco, CA 69028 and Ivan Martinez ("Manufacturer"), an individual located at 2810 Derrick Terrance, San Francisco, CA 69817.
